MetaCap

Vicore Pharma AB Statistics

NASDAQ: VCREHealth CareBiotechnology: Pharmaceutical PreparationsUSD

9.41-0.5049 (-5.09%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Vicore Pharma AB by the numbers

Vicore Pharma AB has a market capitalization of $264.9 million based on 28.16M shares outstanding. With trailing EPS of $-2.04, Vicore Pharma AB is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.8% below its 50-day average and 13.6% below its 200-day average.

Average daily trading volume is 23.31K shares, or about $219,195 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

VCRE valuation vs. peer median

VCRE compared with the median of 8 peer companies
MetricVCREPeer medianDifference
Market cap$264.89M$259.23M+2%
Avg. volume23.31K901.53K-97%

Peer median across 8 companies: EBS, ALT, PRLD, GALT, RLMD, QTTB, FULC, TTRX.

Valuation

Price and trading

Previous close
9.91
Open
9.65
Day range
9.41 – 10.05
52-week range
7.88 – 17.80
Beta
—
Volume
12.97K

Dividends and events

Additional statistics

Market Cap
264.89M
Eps
-2.04
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
17.80
Week52 Low
7.88
Avg Volume
23,306.00
Shares Outstanding
28.16M
Ma50
9.77
Ma200
10.89
Pct From52w High
-47.16%
Pct From52w Low
19.35%

Related